Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amay Parikh

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Plos One|May 26, 2017
Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosisAmay Parikh, John A Rizzo, Pietro Canetta, et al.
Plos One|March 25, 2021
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central FloridaEduardo Oliveira, Amay Parikh, Arnaldo Lopez-Ruiz, et al.
Drugs - Real World Outcomes|July 9, 2022
Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause MortalityGregory M Miller, J Austin Ellis, Rangaprasad Sarangarajan, et al.
Blood Purification|December 11, 2024
Seraph 100 Hemoperfusion for Management of Severe COVID-19: Assessment of Serum and Plasma Analytes Pre- and Post-FiltrationMichael Rouse, Eric R Gann, Joost Brandsma, et al.
Critical Care Explorations|May 4, 2022
A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19Stephen A Chitty, Sarah Mobbs, Brian S Rifkin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 25, 2017
Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trialJulie Thompson, Natasha Jones, Ali Al-Khafaji, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Plos One|May 26, 2017
Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosisAmay Parikh, John A Rizzo, Pietro Canetta, et al.
Plos One|March 25, 2021
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central FloridaEduardo Oliveira, Amay Parikh, Arnaldo Lopez-Ruiz, et al.
Drugs - Real World Outcomes|July 9, 2022
Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause MortalityGregory M Miller, J Austin Ellis, Rangaprasad Sarangarajan, et al.
Blood Purification|December 11, 2024
Seraph 100 Hemoperfusion for Management of Severe COVID-19: Assessment of Serum and Plasma Analytes Pre- and Post-FiltrationMichael Rouse, Eric R Gann, Joost Brandsma, et al.
Critical Care Explorations|May 4, 2022
A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19Stephen A Chitty, Sarah Mobbs, Brian S Rifkin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 25, 2017
Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trialJulie Thompson, Natasha Jones, Ali Al-Khafaji, et al.
Pageof 5